We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $30.1M invested in Adverum Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

11.48% less ownership

Funds ownership: 78.54% → 67.06% (-11%)

17% less funds holding

Funds holding: 70 → 58 (-12)

25% less call options, than puts

Call options by funds: $3K | Put options by funds: $4K

38% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 29

50% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 18

57% less capital invested

Capital invested by funds: $69.8M → $30.1M (-$39.7M)

Holders
58
Holders Change
-12
Holders Change %
-17.14%
% of All Funds
0.76%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
9
Reduced
18
Closed
29
Calls
$3K
Puts
$4K
Net Calls
-$1K
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.15M
2
Millennium Management
Millennium Management
New York
+$958K
3
PWA
Principia Wealth Advisory
Texas
+$930K
4
BCM
BML Capital Management
Indiana
+$882K
5
Citadel Advisors
Citadel Advisors
Florida
+$219K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$7.69M
2
BlackRock
BlackRock
New York
-$2.83M
3
State Street
State Street
Massachusetts
-$826K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$745K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$407K
Name Holding Trade Value Shares
Change 		Change in
Stake
PD
51
Point72 (DIFC)
United Arab Emirates
$484 +$629 +225 New
Wells Fargo
52
Wells Fargo
California
$461 -$34.5K -12,317 -98%
EWA
53
EQ Wealth Advisors
Texas
$348 – – –
AF
54
Allworth Financial
California
$220 – – –
Nisa Investment Advisors
55
Nisa Investment Advisors
Missouri
$181 -$509 -182 -68%
SS
56
SBI Securities
Japan
$181 – – –
PA
57
Parallel Advisors
California
$108 – – –
GIA
58
GHP Investment Advisors
Colorado
$43 – – –
Deutsche Bank
59
Deutsche Bank
Germany
$2 – – –
Franklin Resources
60
Franklin Resources
California
– -$7.69M -1,760,056 Closed
Invesco
61
Invesco
Georgia
– -$218K -49,831 Closed
Bank of New York Mellon
62
Bank of New York Mellon
New York
– -$216K -49,324 Closed
Charles Schwab
63
Charles Schwab
California
– -$214K -49,024 Closed
AQR Capital Management
64
AQR Capital Management
Connecticut
– -$148K -33,823 Closed
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
– -$144K -32,999 Closed
N
66
Nuveen
North Carolina
– -$139K -31,847 Closed
Barclays
67
Barclays
United Kingdom
– -$129K -29,510 Closed
TI
68
Trexquant Investment
Connecticut
– -$81.7K -18,694 Closed
CF
69
Cantor Fitzgerald
New York
– -$67.5K -15,446 Closed
Citigroup
70
Citigroup
New York
– -$64.5K -14,752 Closed
Mirae Asset Global ETFs Holdings
71
Mirae Asset Global ETFs Holdings
Hong Kong
– -$55.1K -12,618 Closed
IIM
72
INTECH Investment Management
Florida
– -$54.2K -12,400 Closed
JP Morgan Chase
73
JP Morgan Chase
New York
– -$44.6K -10,198 Closed
CF
74
Corebridge Financial
Texas
– -$44.5K -10,192 Closed
Simplex Trading
75
Simplex Trading
Illinois
– -$12.1K -4,313 Closed
1 2
3
4

ADVM Hedge Fund Activity: Q2 2025 in Review

58 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2025, worth a combined $30.1M — down 57% from $69.8M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ADVM and 18 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.15M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.69M sold.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2025, down from 70 in Q1 2025.
  • Funds reported $30.1M of Adverum Biotechnologies stock for Q2 2025, down 57% quarter-over-quarter.
  • 18 funds opened new Adverum Biotechnologies positions in Q2 2025 and 29 closed out, a net change of -11 holders.
  • The largest Adverum Biotechnologies buyer in Q2 2025 was Renaissance Technologies, an estimated $1.15M added.
  • The largest Adverum Biotechnologies seller in Q2 2025 was Franklin Resources, an estimated $7.69M sold.

Based on aggregated 13F filings for Q2 2025.